Man Group PLC Moderna, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Man Group PLC holds 228,851 shares of MRNA stock, worth $9.81 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

228,851

Previous 255,735 10.51%

Holding current value

$9.81 Million

Previous $30.4 Million 49.64%

% of portfolio

0.04%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $1.71 Million - $3.36 Million	-26,884 Reduced 10.51%	228,851 $15.3 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $23.5 Million - $38.8 Million	232,673 Added 1008.9%	255,735 $30.4 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $269,854 - $364,905	-3,161 Reduced 12.05%	23,062 $2.46 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $3.96 Million - $5.95 Million	-57,005 Reduced 68.49%	26,223 $2.61 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $758,071 - $995,534	-7,863 Reduced 8.63%	83,228 $8.6 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $605,890 - $820,789	-5,113 Reduced 5.31%	91,091 $11.1 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $7.3 Million - $10.6 Million	53,827 Added 127.02%	96,204 $14.8 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $25.4 Million - $45 Million	-214,401 Reduced 83.5%	42,377 $7.61 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $13.2 Million - $21.7 Million	111,547 Added 76.81%	256,778 $30.4 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $11.6 Million - $17.5 Million	99,014 Added 214.24%	145,231 $20.7 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.17 Million - $2.17 Million	-9,217 Reduced 16.63%	46,217 $7.96 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $8.18 Million - $13.4 Million	36,236 Added 188.75%	55,434 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.07 Million - $6.7 Million	13,831 Added 257.7%	19,198 $7.39 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $313,992 - $567,946	-2,417 Reduced 31.05%	5,367 $1.26 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $2.54 Million - $4.32 Million	-23,225 Reduced 74.9%	7,784 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $653,061 - $1.69 Million	-9,934 Reduced 24.26%	31,009 $3.24 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $2.66 Million - $4.64 Million	-48,970 Reduced 54.46%	40,943 $2.9 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $1.83 Million - $4.93 Million	61,638 Added 217.99%	89,913 $5.77 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $514,286 - $913,451	-28,925 Reduced 50.57%	28,275 $847,000
Q4 2019 Feb 18, 2020	BUY	$13.93 - $21.28 $796,796 - $1.22 Million	57,200 New	57,200 $1.12 Million
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $1.32 Million - $2.72 Million	-96,104 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.45 - $23.7 $3.17 Million - $5.19 Million	-219,197 Reduced 69.52%	96,104 $1.96 Million
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $4.26 Million - $5.93 Million	315,301 New	315,301 $4.81 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account